Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.
2.

Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.

Li L, Mei TH, Zhou XD, Zhang XG.

Ai Zheng. 2009 Jan;28(1):60-3. Epub 2009 Jan 16.

PMID:
19448419
3.
4.

Matrix metalloproteinase activity in early-stage lung cancer.

Weng Y, Cai M, Zhu J, Geng J, Zhu K, Jin X, Ding W.

Onkologie. 2013;36(5):256-9. doi: 10.1159/000350304. Epub 2013 Apr 5.

5.

Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.

Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.

Cancer. 2005 Apr 15;103(8):1676-84.

6.

[Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].

Wang J, Miao LJ, Wu YM, Wu YJ, Wang XC.

Ai Zheng. 2006 Jan;25(1):69-72. Chinese.

PMID:
16405753
7.

Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: implications for MMP inhibition therapy.

Pritchard SC, Nicolson MC, Lloret C, McKay JA, Ross VG, Kerr KM, Murray GI, McLeod HL.

Oncol Rep. 2001 Mar-Apr;8(2):421-4.

PMID:
11182067
8.

Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcome.

Stenvold H, Donnem T, Andersen S, Al-Saad S, Al-Shibli K, Busund LT, Bremnes RM.

Lung Cancer. 2012 Feb;75(2):235-41. doi: 10.1016/j.lungcan.2011.06.010. Epub 2011 Jul 18.

PMID:
21764478
9.

Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer.

Byun JH, Lee MA, Roh SY, Shim BY, Hong SH, Ko YH, Ko SJ, Woo IS, Kang JH, Hong YS, Lee KS, Lee AW, Park GS, Lee KY.

Jpn J Clin Oncol. 2006 May;36(5):263-8. Epub 2006 May 30.

PMID:
16735371
10.

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer.

Shou Y, Hirano T, Gong Y, Kato Y, Yoshida K, Ohira T, Ikeda N, Konaka C, Ebihara Y, Zhao F, Kato H.

Br J Cancer. 2001 Nov 30;85(11):1706-12.

11.

[Prognostic impact of matrix metalloproteinases 2,9, and 11 in stromal cells stage I non-small cell lung cancer].

Drác P, Klein J, Tichý T, Kolek V, Skarda J.

Cas Lek Cesk. 2007;146(1):45-7. Czech.

PMID:
17310584
12.

Expression of membrane-type-1-matrix metalloproteinase and metalloproteinase-2 in nonsmall cell lung carcinomas.

Yamamura T, Nakanishi K, Hiroi S, Kumaki F, Sato H, Aida S, Kawai T.

Lung Cancer. 2002 Mar;35(3):249-55.

PMID:
11844598
13.

Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.

Katayama A, Bandoh N, Kishibe K, Takahara M, Ogino T, Nonaka S, Harabuchi Y.

Clin Cancer Res. 2004 Jan 15;10(2):634-40.

14.

Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.

Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H, Isaka K, Saarialho-Kere U.

J Pathol. 2004 Jan;202(1):14-22.

PMID:
14694517
15.

[Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma].

Zhang HZ, Wei YP, Li HG, Wang M, Liu JG, Wu C.

Nan Fang Yi Ke Da Xue Xue Bao. 2006 Sep;26(9):1307-10. Chinese.

16.

MT2-MMP expression associates with tumor progression and angiogenesis in human lung cancer.

Chen L, Zhou Q, Xu B, Liu J, Shi L, Zhu D, Wu C, Jiang J.

Int J Clin Exp Pathol. 2014 May 15;7(6):3469-77. eCollection 2014.

17.

Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.

Yamamoto H, Vinitketkumnuen A, Adachi Y, Taniguchi H, Hirata T, Miyamoto N, Nosho K, Imsumran A, Fujita M, Hosokawa M, Hinoda Y, Imai K.

Carcinogenesis. 2004 Dec;25(12):2353-60. Epub 2004 Aug 27.

PMID:
15333466
18.

Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.

Zheng S, Chang Y, Hodges KB, Sun Y, Ma X, Xue Y, Williamson SR, Lopez-Beltran A, Montironi R, Cheng L.

Anticancer Res. 2010 Mar;30(3):713-8.

PMID:
20392988
19.
20.

Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum mmp-9 activity, pathologic type, and prognosis.

El-Badrawy MK, Yousef AM, Shaalan D, Elsamanoudy AZ.

J Bronchology Interv Pulmonol. 2014 Oct;21(4):327-34. doi: 10.1097/LBR.0000000000000094.

PMID:
25321452

Supplemental Content

Support Center